These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 26505672)
21. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs. Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346 [TBL] [Abstract][Full Text] [Related]
22. Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells. Ichiyanagi N; Fujimori K; Yano M; Ishihara-Fujisaki C; Sone T; Akiyama T; Okada Y; Akamatsu W; Matsumoto T; Ishikawa M; Nishimoto Y; Ishihara Y; Sakuma T; Yamamoto T; Tsuiji H; Suzuki N; Warita H; Aoki M; Okano H Stem Cell Reports; 2016 Apr; 6(4):496-510. PubMed ID: 26997647 [TBL] [Abstract][Full Text] [Related]
24. No effect on SOD1 splicing by TARDP or FUS mutations. Belzil VV; Daoud H; Dion PA; Rouleau GA Arch Neurol; 2011 Mar; 68(3):395-6. PubMed ID: 21403029 [No Abstract] [Full Text] [Related]
25. From nucleation to widespread propagation: A prion-like concept for ALS. Maniecka Z; Polymenidou M Virus Res; 2015 Sep; 207():94-105. PubMed ID: 25656065 [TBL] [Abstract][Full Text] [Related]
26. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis. Alrafiah AR In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420 [TBL] [Abstract][Full Text] [Related]
27. [Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor]. Aoki M; Warita H; Suzuki N; Itoyama Y Rinsho Shinkeigaku; 2009 Nov; 49(11):814-7. PubMed ID: 20030218 [TBL] [Abstract][Full Text] [Related]
28. Amyotrophic lateral sclerosis with long lasting disease course and SOD1 and TARDBP mutations: Report of two cases and overview of the literature. Lucchesi C; Caldarazzo Ienco E; Fabbrini M; Pasquali L; Lo Gerfo A; Fogli A; Siciliano G Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):137-139. PubMed ID: 27494151 [No Abstract] [Full Text] [Related]
29. Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Haukedal H; Freude K J Mol Biol; 2019 Apr; 431(9):1818-1829. PubMed ID: 30763568 [TBL] [Abstract][Full Text] [Related]
30. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS. Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; Atkin JD Acta Neuropathol; 2015 Nov; 130(5):679-97. PubMed ID: 26298469 [TBL] [Abstract][Full Text] [Related]
38. The review of the methods to obtain non-neuronal cells to study glial influence on Amyotrophic Lateral Sclerosis pathophysiology at molecular level in vitro. Scorisa JM; Duobles T; Oliveira GP; Maximino JR; Chadi G Acta Cir Bras; 2010 Jun; 25(3):281-9. PubMed ID: 20498942 [TBL] [Abstract][Full Text] [Related]
39. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations. Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504 [TBL] [Abstract][Full Text] [Related]
40. Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosis. Nikel LM; Talbot K; Vahsen BF Bioessays; 2024 Jul; 46(7):e2400054. PubMed ID: 38713169 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]